NOV 22, 2017 01:59 PM PST

Bi-Specific Antibodies- New Improvements to Cancer Immunotherapy

In the last several years, immunotherapy has been hailed as the therapeutic breakthrough for cancer that we’ve all been waiting for.  The ability to utilize and manipulate our own immune systems to eradicate cancer is not only highly promising, but has already proven effective in a subset of patients in the clinic – and this is not just in one cancer type – but many.  A lot of attention has been given to immune checkpoint blockade in highly mutagenic cancers such as melanoma and those of the lung, as well as to chimeric antigen receptor T-cell therapy (CAR-T therapy), but a third category is now gaining more attention as well.  This category is that of bispecific antibodies, or BsAbs.   Interestingly, bispecific antibodies were originally hypothesized to be a method to combat cancer as early as the 1980s.  These work through their affinity to two different targets which act to promote tumor progression.  By binding these targets, they in essence block their ability to interact with their normal partners and are then unable exert their oncogenic effects.  They also have the ability to link therapeutic agents to cancer cells to deliver the desired blow of the therapies.  This video, published by Roche in May of 2016, details the use of T-cell bispecific antibodies for use in cancer.

Sources: Roche, Youtube, Nature Reviews

 

 

 

 

About the Author
You May Also Like
MAY 14, 2018
Drug Discovery
MAY 14, 2018
Gilenya: First Treatment for Pediatric MS
   A drug known as Gilenya (fingolimod), which was first approved in 2010 for the treatment of Multiple Sclerosis (MS) in adult patients, was rec...
JUN 13, 2018
Cancer
JUN 13, 2018
Tailored vaccine boosts survival for some brain cancer patients
In a new multicenter clinical trial, a personalized vaccine improved the survival rates of some people with the deadly brain cancer glioblastoma. Currently...
JUN 29, 2018
Technology
JUN 29, 2018
Amazon Buys Online Pharmacy PillPack, Drugstore Stocks Tumble
Online Pharmacy PillPack Now Belongs to Amazon...
JUL 04, 2018
Drug Discovery
JUL 04, 2018
First Drug Approved for The Treatment of Hyperhidrosis
Hyperhidrosis is a chronic skin condition that results in the increased production of sweat than needed. A certain amount of sweat is normally produced to ...
JUL 17, 2018
Videos
JUL 17, 2018
Novartis Ends Antibiotic Research
The United Nations has warned that by 2050, antibiotic-resistant microbes might kill ten million people every year....
AUG 08, 2018
Drug Discovery
AUG 08, 2018
Injection Improves Corneal Transplant Outcomes
The common form of tissue transplant is the corneal transplant. Corneal transplantation is performed to correct visual loss that has occurred when the corn...
Loading Comments...